Comparison 4. Complete response rate.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 All trials (previously untreated patients) | 2 | 535 | Risk Ratio (M‐H, Random, 95% CI) | 1.11 [0.64, 1.92] |
2 Rituximab‐containing regimen (previously untreated patients) | 2 | 535 | Risk Ratio (M‐H, Random, 95% CI) | 1.11 [0.64, 1.92] |
2.1 Rituximab in both arms | 1 | 134 | Risk Ratio (M‐H, Random, 95% CI) | 1.37 [1.11, 1.70] |
2.2 No rituximab in both arms | 1 | 401 | Risk Ratio (M‐H, Random, 95% CI) | 0.84 [0.53, 1.33] |